Beam Therapeuticsinc Stock Story

BEAM Stock  USD 33.96  0.74  2.23%   
About 64% of all Beam TherapeuticsInc's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Beam TherapeuticsInc suggests that some traders are interested. Beam TherapeuticsInc's investor sentiment overview provides quick insight into current market opportunities from investing in Beam TherapeuticsInc. The current market sentiment, together with Beam TherapeuticsInc's historical and current headlines, can help investors time the market. In addition, many technical investors use Beam TherapeuticsInc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Beam TherapeuticsInc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Beam daily returns and investor perception about the current price of Beam TherapeuticsInc as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Beam TherapeuticsInc.

Beam TherapeuticsInc Latest Timeline

Beam TherapeuticsInc is listed for 33.96. About 90.0% of the company shares are held by institutions such as insurance companies. The book value of Beam TherapeuticsInc was currently reported as 12.47. The company recorded a loss per share of 1.72. Beam TherapeuticsInc last dividend was issued on the February 4, 2014. The entity had 2:1 split on the October 26, 1990.
When determining whether Beam TherapeuticsInc is a strong investment it is important to analyze Beam TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beam TherapeuticsInc's future performance. For an informed investment choice regarding Beam Stock, refer to the following important reports:
Check out Beam TherapeuticsInc Hype Analysis, Beam TherapeuticsInc Correlation and Beam TherapeuticsInc Performance.
To learn how to invest in Beam Stock, please use our How to Invest in Beam TherapeuticsInc guide.
Note that the Beam TherapeuticsInc information on this page should be used as a complementary analysis to other Beam TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Beam Stock analysis

When running Beam TherapeuticsInc's price analysis, check to measure Beam TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beam TherapeuticsInc is operating at the current time. Most of Beam TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Beam TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beam TherapeuticsInc's price. Additionally, you may evaluate how the addition of Beam TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Beam TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam TherapeuticsInc. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.72)
Revenue Per Share
4.896
Quarterly Revenue Growth
14.78
Return On Assets
(0.08)
Return On Equity
(0.15)
The market value of Beam TherapeuticsInc is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Beam TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam TherapeuticsInc's market value can be influenced by many factors that don't directly affect Beam TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.